BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31616592)

  • 1. Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer.
    Chen R; Gong Y; Zou D; Wang L; Yuan L; Zhou Q
    PeerJ; 2019; 7():e7804. PubMed ID: 31616592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
    Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
    Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages.
    Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H
    BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder.
    Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH
    Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.
    Jääskeläinen MM; Tiainen S; Siiskonen H; Ahtiainen M; Kuopio T; Rönkä A; Kettunen T; Hämäläinen K; Rilla K; Harvima I; Mannermaa A; Auvinen P
    Breast Cancer Res Treat; 2023 Sep; 201(2):183-192. PubMed ID: 37428418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating CD45RO
    Hu Z; Gu X; Zhong R; Zhong H
    J Thorac Dis; 2018 Apr; 10(4):2089-2099. PubMed ID: 29850112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer.
    Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
    J Pathol Clin Res; 2021 Sep; 7(5):517-527. PubMed ID: 34076969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of immunoscore related markers in bladder cancer.
    Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
    BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
    Liu L; Long M; Su S; Wang L; Liu J
    PeerJ; 2024; 12():e16747. PubMed ID: 38223758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune stromal features in cervical squamous cell carcinoma are prognostic factors for distant metastasis: A retrospective study.
    Cao L; Sun PL; He Y; Yao M; Gao H
    Pathol Res Pract; 2020 Mar; 216(3):152751. PubMed ID: 31776057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.
    Mohammadi Y; Ahmadvand S; Mirtalebi M; Ashraf MJ; Khademi B; Ghaderi A
    Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S133-S142. PubMed ID: 36319566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness.
    Tavana S; Mokhtari Z; Sanei MH; Heidari Z; Dehghanian AR; Faghih Z; Rezaei M
    Cancer Cell Int; 2023 Feb; 23(1):23. PubMed ID: 36765348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
    Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
    Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity.
    Ishikawa Y; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Tokodai K; Fujishima F; Kawanabe S; Katabami T; Ikeya A; Yamashita M; Oki Y; Nanjo H; Satoh F; Ito A; Unno M; Kamei T; Sasano H; Suzuki T
    J Steroid Biochem Mol Biol; 2024 Apr; 238():106462. PubMed ID: 38232786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
    Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
    J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.